Pneumatic conveying systems move powders, granules and pellets through a sealed pipeline using compressed air or vacuum, and they are split into two operating regimes: dilute phase (high velocity, low solids loading) and dense phase (low velocity, high solids loading, often pulsed or slugs) [S1][S4].
For pharmaceutical distribution the real decision is not phase alone, it is the combination of (a) pressure vs vacuum, (b) dilute vs dense, and (c) how the receiving end handles dust containment, wash-down, and cleanability. The configuration drives API degradation, line losses, and whether the line meets a GMP containment target [S2][S9].
Why pharmaceutical plants pick pressure or vacuum first
Pressure conveying is generally selected for higher throughputs, longer conveying distances or multiple discharge points, whereas vacuum conveying is often preferred where dust containment, hygienic production or operator safety are critical [S2]. In API suites a vacuum receiver mounted directly above a reactor or a tablet-press feed hopper is the common pattern because suction keeps any leak path inward and simplifies HEPA filtration on the vacuum side [S2][S9].
Where a line has to run more than 30-50 m, serve several floors, or feed multiple destinations from one source, a positive-pressure setup (often with a rotary airlock feeder) typically wins on energy and pipeline diameter [S1][S4]. A standard conveying system always has five basic building blocks: a pick-up point, the convey tubing, a drive (compressor, blower or vacuum pump), a receiver/separator, and a filter/vent unit [S7]. Getting the receiver and filter right is what makes the line GMP-friendly, not the pipe.
Dense phase vs dilute phase: the criteria that actually matter for APIs
Dilute phase conveying uses higher velocities and lower pressures to transport lighter materials over longer distances, making it a versatile choice for many industrial processes; dense phase conveying operates at lower velocity and higher pressures, providing gentle handling of fragile or abrasive materials, minimizing product breakage, and improving energy efficiency [S4][S10]. For tablet granulations, micronised APIs and any blend with a median particle size below 100 micrometres, dense-phase slugs or pulsed-blow systems cut attrition by holding line velocity roughly one third to one fifth of a dilute-phase line [S4][S5].
Selection hinges on material characteristics: particle size distribution, bulk density, flowability, moisture content, abrasiveness and product fragility determine pipeline diameter, conveying velocity and product-separation choice [S2]. A quick spec-side comparison for an engineer sizing a new line:
Criterion 1, Material fragility: dilute phase suits robust excipients (lactose, microcrystalline cellulose coarse grades); dense phase suits friable APIs, coated particles, granules above 200 micrometres where attrition would shift the PSD [S4][S5]. Criterion 2, Containment target: vacuum dense phase receivers paired with bag-in/bag-out filtration reach OEB 4-5 with the right valve train; pressure dilute phase is more common at OEB 1-3 because leakage is harder to contain [S2][S9]. Criterion 3, Distance and routing: long horizontal runs above 80 m or with more than 6 bends push the choice toward pressure dilute for non-fragile material, and toward pressure dense for fragile material [S1][S4]. Criterion 4, Energy per kilogram: dense phase typically consumes less compressed air per kilogram moved at the same throughput, but requires a higher-pressure compressor (typically 2-4 bar g vs 0.5-1 bar g for dilute) [S1][S4][S5].
System architecture, valves and filtration for GMP cleanability
The core principle is using air to transport bulk materials through a pipeline, with the sealed, pressurised air acting as both the energy source and the transportation medium; key system elements typically include a blower or compressor, feeder, receiver, filter, rotary airlock valve, and conveying line [S1]. For pharmaceutical duty those five elements have pharma-specific variants: quick-clean rotary valves with no dead-leg pockets, polished stainless conveying tubes (typically 304/316L, Ra below 0.8 micrometre on product-contact surfaces), and vent filters rated for the line volume with HEPA H13/H14 final stages on vacuum receivers [S5][S9].
Gericke's dense-phase line is built around dust-tight transport, gentle product handling and energy-efficient pneumatic transfer, with diverter valves and a dedicated conveying controller (GUC-C) that lets recipes switch routes without opening the line, a pattern that matters when one line feeds multiple SKUs [S5]. Coperion's P-Series pneumatic conveyors are explicitly designed to convey delicate materials such as tablet granulations and active pharmaceutical ingredients, which is the niche where dense-phase vacuum typically wins [S9]. For plants that also handle power distribution on the same skid, control cabinets and distribution cabinet layouts follow the same clean-room zoning as the conveyor, with VFDs for the blower kept outside the room.
Limits, failure modes and what to test before sign-off
Atmospheric conditions such as ambient temperature and humidity directly affect both dense and dilute phase performance; high humidity can cause bulk materials to absorb moisture, leading to clumping or blockages inside the line, so pharma-grade systems in tropical or coastal plants usually add dehumidified conveying air and pre-drying on the receiver vent [S4]. Common field failure modes: (1) rat-holing at the pick-up when the feeder's air bleed is mis-tuned, (2) particle segregation at bends when the elbow radius is below 5D, (3) filter blinding when the receiver vent area is undersized for the batch peak rate, and (4) cross-contamination between products when a diverter valve has a non-sanitary dead volume [S1][S4][S5].
Acceptance testing for a new pharma line should include a placebo run with the actual product PSD, a minimum 30-minute steady-state trial measuring specific energy (kWh per tonne) and line pressure drop across each bend, plus a smoke or DOP leak test on the receiver to confirm containment class [S2][S4][S9]. Cross-reference the spec to a cable distribution cabinet standard for plant-side wiring and to the conveying reference page for the broader material-handling taxonomy. The gear pump selection for pharmaceutical manufacturing spec map is a useful parallel read because pump-side and conveyor-side decisions in an API suite share the same containment and CIP logic.
Market and sourcing context for 2026 builds
The pneumatic conveying system market shows strong adoption in food processing, pharmaceuticals, chemicals, cement, and plastics, with pharmaceuticals cited as one of the higher-growth end-use segments as continuous-manufacturing and OEB-4/5 containment drive retrofit demand [S3]. Rieco, Gericke, Hosokawa Alpine, Coperion and AZO are the names that recur in pharma tenders, each with a slightly different product mix: dense-phase vacuum skids (Coperion P-Series, Gericke), pressure dilute-phase for high-volume excipient transfer, and integrated powder-processing lines that bundle mixing, drying and conveying under one control philosophy [S2][S5][S8][S9].
Two trackable signals to watch for 2026 specifiers: continuous-manufacturing line-build announcements in oral-solid-dosage (these typically specify dense-phase vacuum with wash-in-place receivers) and compressor-side electrification projects where oil-free screw or turbo blowers replace legacy lobe blowers, cutting both particle-oil contamination risk and specific energy per tonne by double-digit percentages [S2][S3][S5]. For related material-handling context outside the pneumatic niche, the mesh belt conveyor advantages and disadvantages guide is a useful contrast for plants weighing a hybrid line.